Cargando…
The SARS-CoV-2 spike L452R-E484Q variant in the Indian B.1.617 strain showed significant reduction in the neutralization activity of immune sera
To assess the impact of the key non-synonymous amino acid substitutions in the RBD of the spike protein of SARS-CoV-2 variant B.1.617.1 (dominant variant identified in the current India outbreak) on the infectivity and neutralization activities of the immune sera, L452R and E484Q (L452R-E484Q varian...
Autores principales: | Li, Gen, Zhou, Zhongcheng, Du, Peng, Yu, Meixing, Li, Ning, Xiong, Xinxin, Huang, Hong, Liu, Zhihai, Dai, Qinjin, Zhu, Jie, Guo, Chengbin, Wu, Shanyun, Baptista-Hon, Daniel T, Miao, Man, Ming, Lam Wai, Wu, Yong, Zeng, Fanxin, Zhang, Charlotte L, Zhang, Edward D, Song, Haifeng, Liu, Jianghai, Lau, Johnson Yiu-Nam, Xiang, Andy P, Zhang, Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8385834/ https://www.ncbi.nlm.nih.gov/pubmed/35693215 http://dx.doi.org/10.1093/pcmedi/pbab016 |
Ejemplares similares
-
SARS-CoV-2 B.1.617 Mutations L452R and E484Q Are Not Synergistic for Antibody Evasion
por: Ferreira, Isabella A T M, et al.
Publicado: (2021) -
Antibody-Mediated Neutralization of Authentic SARS-CoV-2 B.1.617 Variants Harboring L452R and T478K/E484Q
por: Wilhelm, Alexander, et al.
Publicado: (2021) -
Reduced neutralization of SARS-CoV-2 B.1.617 variant by convalescent and vaccinated sera
por: Hu, Jie, et al.
Publicado: (2021) -
Assessment of infectivity and the impact on neutralizing activity of immune sera of the COVID-19 variant, CAL.20C
por: Zhou, Zhongcheng, et al.
Publicado: (2021) -
SARS-CoV-2 delta (B.1.617.2) spike protein adjuvanted with Alum-3M-052 enhances antibody production and neutralization ability
por: Huang, Hong, et al.
Publicado: (2023)